Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

raxibacumab

Known as: raxibacumab monoclonal antibody, human 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
BACKGROUND Raxibacumab is a monoclonal antibody against protective antigen, which is the cell-binding part of Bacillus anthracis… Expand
2016
2016
Anthrax, caused by Bacillus anthracis (B anthracis), poses a potential threat as a bioterror agent because after inhalation, the… Expand
2015
2015
On December 14, 2012, the FDA approved Raxibacumab, the first monoclonal antibody product developed under Project BioShield to… Expand
2015
2015
BackgroundLethal and edema toxin contribute to shock and lethality with Bacillus anthracis. We showed previously in a 96-h… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Review
2014
Review
2014
Anthrax is a highly contagious and potentially fatal human disease caused by Bacillus anthracis, an aerobic, Gram-positive, spore… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
2014
2014
ABSTRACT Although antibiotics treat bacteremia in inhalational anthrax, pathogenesis is mainly driven by bacterial exotoxins… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
2013
2013
Inhaled Bacillus anthracis spores germinate and the subsequent vegetative growth results in bacteremia and toxin production… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
2010
2010
  • S. Antoniu
  • Expert opinion on investigational drugs
  • 2010
  • Corpus ID: 577029
Importance of the field: Inhalational anthrax is a disease with a high lethality potential and current therapeutic interventions… Expand
Highly Cited
2009
Highly Cited
2009
BACKGROUND Inhalational anthrax caused by Bacillus anthracis is associated with high mortality primarily due to toxin-mediated… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Review
2009
Review
2009
Raxibacumab (ABthrax) is a human IgG1 monoclonal antibody against Bacillus anthracis protective antigen. HGS is currently… Expand